Daptomycin

NDC 70594-034 · Xellia Pharmaceuticals USA LLC

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameDaptomycin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DAPTOMYCIN

Strength500 mg/10mL

Pharmacologic classLipopeptide Antibacterial [EPC], Lipopeptides [CS]

Marketing categoryANDA

Packages

70594-034-01 — 1 VIAL, SINGLE-USE in 1 CARTON (70594-034-01) / 10 mL in 1 VIAL, SINGLE-USE

70594-034-02 — 1 VIAL, SINGLE-USE in 1 CARTON (70594-034-02) / 10 mL in 1 VIAL, SINGLE-USE

J0878 — Injection, daptomycin, 1 mg Medicare Part B payment limit (ASP + 6%): $0.03

FDA lists these products with the same active ingredient.

60505-6229 — Daptomycin, 60977-145 — daptomycin, 63323-371 — Daptomycin, 67184-0549 — Daptomycin, 67457-813 — daptomycin, 67457-941 — daptomycin, 68001-376 — Daptomycin, 70377-093 — Daptomycin, 70436-033 — daptomycin, 70511-182 — Daptomycin, 70594-053 — Daptomycin, 70594-060 — daptomycin, 70594-066 — daptomycin, 71288-016 — DAPTOMYCIN, 71288-017 — DAPTOMYCIN, 71839-107 — daptomycin, 71839-108 — daptomycin, 72572-100 — Daptomycin, 72572-102 — Daptomycin, 72572-158 — daptomycin, +25 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.